Jason Hulse Murray sold $2.2M of PACS
Co-Founder, CEO & Chairman at PACS Group, Inc.. 51,887 shares at an average of $43.12, traded Sep 4, 2026, filed Sep 9, 2026.
Score components
- +25RoleCEO
- +25Trade size$2.2M at market
- 0Share of holdings soldSold 0.1% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002014386-26-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -22,829 | $42.68 | $974k | 54,603,924 | 34 d ago |
| Sep 4, 2026 | SOpen-market sale Common Stock10b5-1 | -243 | $43.14 | $10k | 54,603,681 | 34 d ago |
| Sep 8, 2026 | SOpen-market sale Common Stock10b5-1 | -3,056 | $42.80 | $131k | 54,600,625 | 34 d ago |
| Sep 8, 2026 | SOpen-market sale Common Stock10b5-1 | -21,001 | $43.59 | $916k | 54,579,624 | 34 d ago |
| Sep 9, 2026 | SOpen-market sale Common Stock10b5-1 | -4,758 | $43.33 | $206k | 54,574,866 | 34 d ago |
Related signals
Other insiders at PACS Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $1.6M 36,692 shares | -0% | |
| 30Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $3.5M 83,308 shares | -0% | |
| 40Moderate | PACS Group, Inc. | Joshua Jergensen President & COO | $1.7M 40,000 shares | -2% | |
| 35Weak | PACS Group, Inc. | Mark Hancock Co Fndr; Exec V Chair | $13M 300,000 shares | -1% | |
| 43Moderate | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $887k 19,617 shares | -0% | |
| 38Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $2.9M 68,113 shares | -0% | |
| 33Weak | PACS Group, Inc. | Mark Hancock Co Fndr; Exec V Chair | $8.1M 200,000 shares | -0% | |
| 22Weak | PACS Group, Inc. | Michelle Renee Lewis Chief Accounting Officer | $600k 15,000 shares | -4% | |
| 33Weak | PACS Group, Inc. | Mark Hancock Co Fndr; Exec V Chair | $2.2M 63,680 shares | -0% | |
| 33Weak | PACS Group, Inc. | Mark Hancock Co Fndr; Exec V Chair | $8.6M 236,320 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.